-
Treatment of 1st Relapsed Classical Hodgkin Lymphoma_Vaishalee Kenkre, MD; #IUCLS22
16:00
-
Cellular Therapy in Lymphoma: Where Are We Now?_Peter Riedell, MD #IUCLS22
38:36
-
Targeted agents in Follicular Lymphoma (Small Molecules)_Tycel Phillips, MD; #IUCLS22
13:03
-
T-cell Lymphomas: Impact of Classification on Treatment _Neha Mehta-Shah, MD, MSCI; #IUCLS22
19:59
-
What's Now and Next for CLL_Nicole Lamanna, MD; #IUCLS22
20:13
-
CAR T-cell Constructs: Current and Future Options _Tanya Siddiqi, MD; #IUCLS22
20:23
-
Treatment of Relapsed CNS Lymphomas_Andres Ferreri, MD; #IUCLS22
24:37
-
Prognostication and Treatment of Burkitt Lymphoma in the Modern Era_Adam Olszewsk, MD; #IUCLS22
24:35
-
Recent Advances in the Frontline Treatment of DLBCL: Is There a New Standard of Care?_Laurie Sehn, MD, MPH; #IUCLS22
49:11
-
CAR T-Cell Therapy and Emerging Bispecifics for the Treatment of Follicular Lymphoma_Sairah Ahmed, MD; #IUCLS22
20:00
-
HBGL NOS: How to Differentiate and What to Do?_David Scott, MBChB, PhD; #IUCLS22
22:33
- Next Page